On November 6, 2019 Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, reported that the company will participate in the Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper) Annual Meeting in National Harbor, MD, November 7-10, including poster presentations on November 8th and 9th (Press release, Personalis, NOV 6, 2019, View Source [SID1234550543]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The company will showcase ImmunoID NeXT, the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample. ImmunoID NeXT can be used to investigate the key tumor- and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.
Following is a list of abstracts that will be presented at the meeting.
Scientific Poster Presentations
Poster Number & Category
Title & Presenter
Day & Time
Location
P77
Biomarkers, Immune Monitoring, and Novel Technologies
Comprehensive profiling of tumor-immune interaction in anti-PD-1 treated melanoma patients reveals subject-specific tumor escape mechanisms
Presenter: Charles Abbott, Ph.D.
November 8:
12:30 PM – 2:00 PM
and
6:30 PM – 8:00 PM
Poster Hall: Prince George AB
P72
Biomarkers, Immune Monitoring, and Novel Technologies
Comprehensive and accurate prediction of presented neoantigens using ImmunoID NeXT and advanced machine learning algorithms
Presenters: Dattatreya Mellacheruvu, Ph.D. and Rachel Pyke, Ph.D.
November 9:
12:35 PM – 2:05 PM
and
6:30 PM – 8:00 PM
Poster Hall: Prince George AB
P96
Biomarkers, Immune Monitoring, and Novel Technologies
T-cell receptor alpha and beta repertoire profiling using an augmented transcriptome
Presenter: Eric Levy, Ph.D.
November 9:
12:35 PM – 2:05 PM
and
7:00 PM – 8:30 PM
Poster Hall: Prince George AB
Personalis will also be exhibiting during the conference (Booth # 431). Representatives will be available to answer questions about the company’s cancer immunogenomics services.